Amryt Pharma Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
268
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
6
Amryt Pharma General Information
Description
Operator of a commercial-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics. The company offers advanced clinical research and patient-centered care, featuring therapies approved for use in complex conditions and expanded access programs, enabling businesses to provide patients with effective and timely treatments.
Contact Information
Website
www.amrytpharma.com(Operating Subsidiary)
Corporate Office
- 196 High Road Wood Green
- 1 Adam Street
- London N22 8HH
- England, United Kingdom
Corporate Office
- 196 High Road Wood Green
- 1 Adam Street
- London N22 8HH
- England, United Kingdom
Amryt Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Amryt Pharma Comparisons
Industry
Financing
Details
Amryt Pharma Competitors (4)
One of Amryt Pharma’s 4 competitors is Krystal Biotech, a Formerly VC-backed company based in Pittsburgh, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Krystal Biotech | Formerly VC-backed | Pittsburgh, PA | ||||
| Abeona Therapeutics | Corporation | Cleveland, OH | ||||
| Castle Creek Biosciences | Venture Capital-Backed | Exton, PA | ||||
| Regeneron Pharmaceuticals | Formerly VC-backed | Tarrytown, NY |
Amryt Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amryt Pharma Patents
Amryt Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250152674-A1 | Oral octreotide for treatment of disease | Pending | 25-Feb-2022 | ||
| AU-2022231007-A1 | Methods for treating familial chylomicronemia syndrome | Pending | 03-Mar-2021 | ||
| AU-2022231007-A9 | Methods for treating familial chylomicronemia syndrome | Pending | 03-Mar-2021 | ||
| CA-3208189-A1 | Methods for treating familial chylomicronemia syndrome | Pending | 03-Mar-2021 | ||
| EP-4301361-A1 | Methods for treating familial chylomicronemia syndrome | Pending | 03-Mar-2021 | A61K31/4468 |
Amryt Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amryt Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Amryt Pharma Acquisitions (6)
Amryt Pharma’s most recent deal was a Merger/Acquisition with Amryt Endo for . The deal was made on 05-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Amryt Endo | 05-Aug-2021 | Merger/Acquisition | Drug Delivery | ||
| Cala Medical | 12-Oct-2020 | Merger/Acquisition | Therapeutic Devices | ||
| Aegerion Pharmaceuticals | 24-Sep-2019 | Merger/Acquisition | Drug Discovery | ||
| Birken (Germany) | 18-Apr-2016 | Merger/Acquisition | Pharmaceuticals | ||
| Fastnet Equity | 18-Apr-2016 | Merger/Acquisition | Energy Exploration |
Amryt Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sterling Green Group | Stockport, United Kingdom |
Amryt Pharma FAQs
-
When was Amryt Pharma founded?
Amryt Pharma was founded in 2015.
-
Where is Amryt Pharma headquartered?
Amryt Pharma is headquartered in London, United Kingdom.
-
What is the size of Amryt Pharma?
Amryt Pharma has 268 total employees.
-
What industry is Amryt Pharma in?
Amryt Pharma’s primary industry is Drug Discovery.
-
Is Amryt Pharma a private or public company?
Amryt Pharma is a Private company.
-
What is the current valuation of Amryt Pharma?
The current valuation of Amryt Pharma is .
-
What is Amryt Pharma’s current revenue?
The current revenue for Amryt Pharma is .
-
How much funding has Amryt Pharma raised over time?
Amryt Pharma has raised $280M.
-
Who are Amryt Pharma’s investors?
Amati Global Investors, Aquilo Capital Management, Athyrium Capital Management, Fastnet Equity, and Highbridge Capital Management are 5 of 6 investors who have invested in Amryt Pharma.
-
Who are Amryt Pharma’s competitors?
Krystal Biotech, Abeona Therapeutics, Castle Creek Biosciences, and Regeneron Pharmaceuticals are competitors of Amryt Pharma.
-
When was Amryt Pharma acquired?
Amryt Pharma was acquired on 12-Apr-2023.
-
Who acquired Amryt Pharma?
Amryt Pharma was acquired by Chiesi Farmaceutici.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
